ADXS

Ayala Pharmaceuticals (PK) (ADXS)

Ayala Pharmaceuticals Inc (PK)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ADXS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/06	21 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/03/06	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/03/05	22 : 16	Edgar (US Regulatory)	Form DEFM14C - Definitive information statement relating to merger or acquisition	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/24	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/21	07 : 22	Edgar (US Regulatory)	Form PREM14C - Preliminary information statements relating to merger or acquisition	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/15	06 : 26	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/13	04 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/13	01 : 58	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/12	22 : 27	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/10	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/02/06	22 : 51	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2024/01/04	06 : 18	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/21	23 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/21	23 : 00	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/20	23 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/16	06 : 04	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/09	06 : 01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/04	00 : 46	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/04	00 : 45	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/04	00 : 43	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/11/03	05 : 05	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/31	20 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/31	20 : 05	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/23	19 : 45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/23	19 : 45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/23	19 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/23	19 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/10/21	05 : 31	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/09/29	19 : 13	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
2023/09/29	19 : 10	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)